Single agent and combination studies of pralatrexate and molecular correlates of sensitivity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6606063.pdf
Reference25 articles.
1. Appling DR (1991) Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB J 5: 2645–2651
2. Assaraf YG (2007) Molecular basis of antifolate resistance. Cancer Metastasis Rev 26: 153–181
3. Azzoli CG, Krug LM, Gomez J, Miller VA, Kris MG, Ginsberg MS, Henry R, Jones J, Tyson L, Dunne M, Pizzo B, Farmer A, Venkatraman E, Steffen R, Sirotnak FM (2007) A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors. Clin Cancer Res 13: 2692–2698
4. Bièche I, Parfait B, Laurendeau I, Girault I, Vidaud M, Lidereau R (2001) Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene 20: 8109–8115
5. Chabner BA, Allegra CJ, Curt GA, Clendeninn NJ, Baram J, Koizumi S, Drake JC, Jolivet J (1985) Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest 76: 907–912
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer;BioData Mining;2024-02-21
2. Pralatrexate inhibited the replication of varicella zoster virus and vesicular stomatitis virus: An old dog with new tricks;Antiviral Research;2024-01
3. Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma;OMICS: A Journal of Integrative Biology;2022-12-01
4. Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2022-10-20
5. Repositioning anticancer drugs as novel COVID-19 antivirals: targeting structural and functional similarities between viral proteins and cancer;Expert Reviews in Molecular Medicine;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3